KYOUNG JIN KIM: Open Payments
NPI 1609392919 · GARDENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 51 payments from 11 companies in 2025. Trend: 2023 $384 · 2024 $590 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $236 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $188 |
| Amgen Inc. | 11 | $174 |
| Sumitomo Pharma America, Inc. | 4 | $93 |
| Lilly USA, LLC | 3 | $84 |
| Exact Sciences Corporation | 3 | $79 |
| SHIELD THERAPEUTICS INC | 1 | $31 |
| Novo Nordisk Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $27 |
| SCILEX PHARMACEUTICALS INC. | 1 | $21 |
Products named: Kerendia, EVENITY, CREON, LINZESS, GEMTESA, Cologuard Collection Kit, JARDIANCE, OTEZLA.
Industry payments across CA — which companies pay providers there.
